Depression is a persistent state of low mood, low energy or anhedonia and is considered a common mental disorder. It is associated with a wide range of significant emotional, psychological and physical symptoms. It can have a significant impact on people’s functioning, and mental ill health is estimated to cost the UK economy £94 billion per year. An estimated 40% of GP consultations are about mental health, and it is important that depression is appropriately diagnosed and managed. This article reviews the most recent National Institute for Health and Care Excellence guidelines and also gives special consideration to managing depression alongside physical comorbidities and in patients from different cultures.
Get full access to this article
View all access options for this article.
References
1.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, fourth edition. Washington, DC: APA.
2.
American Psychiatric Association (ed.) (2013) ‘Cultural Formulation Interview’, in Diagnostic and statistical manual of mental disorders. 5th. Washington, DC: APA, pp. 749–759.
3.
BarnardKPevelerRCHoltRIG (2013) Antidepressant medication as a risk factor for type 2 diabetes and impaired glucose regulation. Diabetes Care36(10): 3337–3345. DOI: 10.2337/dc13-0560.
4.
Baumeister H, Hutter N and Bengel J (2012) Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Cochrane Database of Systematic Reviews 12: art. no.: CD008381. DOI: 10.1002/14651858.CD008381.pub2.
5.
BensonJ (2006) A culturally sensitive consultation model. Australian E-Journal for the Advancement of Mental Health5(2): 97–104. DOI: 10.5172/jamh.5.2.97.
6.
CuthillFMEspieCACooperS-A (2003) Development and psychometric properties of the Glasgow Depression Scale for people with a learning disability: Individual and carer supplement versions. The British Journal of Psychiatry182(4): 347–353. DOI: 10.1192/bjp.182.4.347.
7.
EgedeLEEllisC (2010) Diabetes and depression: Global perspectives. Diabetes Research and Clinical Practice87(3): 302–312. DOI: 10.1016/j.diabres.2010.01.024.
8.
EkersDRichardsDMcMillanD, et al.(2011) Behavioural activation delivered by the non-specialist: Phase II randomised controlled trial. British Journal of Psychiatry198(1): 66–72. DOI: 10.1192/bjp.bp.110.079111.
9.
IsmailKWinkleyKRabe-HeskethS (2004) Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. The Lancet363(9421): 1589–1597. DOI: 10.1016/S0140-6736(04)16202-8.
10.
JacksonMJTurkingtonD (2005) Depression and anxiety in epilepsy. Journal of Neurology, Neurosurgery & Psychiatry76(suppl 1): i45 LP i47. DOI: 10.1136/jnnp.2004.060467.
11.
JickHKayeJAJickSS (2004) Antidepressants and the risk of suicidal behaviors. JAMA292(3): 338–343. DOI: 10.1001/jama.292.3.338.
KroenkeKSpitzerRWilliamsJ (2003) The Patient Health Questionnaire-2: Validity of a two-item depression screener. Medical Care41(11): 1284–1292.
14.
LustmanPJAndersonRJFreedlandKE, et al.(2000) Depression and poor glycemic control: A meta-analytic review of the literature. Diabetes Care23(7): 934 LP 942. DOI: 10.2337/diacare.23.7.934.
15.
McHughBKrishnadasR (2011) Guide to safely withdrawing antidepressants in primary care. Prescriber22(17): 36–40.
16.
MitchellAJChanMBhattiH, et al.(2011) Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. The Lancet Oncology12(2): 160–174. DOI: 10.1016/S1470-2045(11)70002-X.
17.
NaylorCParsonageMMcDaidD, et al.(2012) Long Term Conditions and Mental Health, London: The King’s Fund.
NHS England. (2019) The NHS long term plan (no. 1). Available at: www.longtermplan.nhs.uk (accessed 01 October 2020).
21.
NICE (2009a) Depression in adults: Recognition and management. Available at: www.nice.org.uk/guidance/cg90 (accessed 01 October 2020).
22.
NICE (2009b) Depression in adults with a chronic physical health problem: Recognition and management. Available at: www.nice.org.uk/guidance/cg91/chapter/1-Guidance (accessed 01 October 2020).
Stansfeld S, Clark C, Bebbington P, King M, Jenkins R, Hinchliffe S. (2016) ‘Chapter 2: Common mental disorders’ in McManus S, Bebbington P, Jenkins R, Brugha T. (eds) Mental health and wellbeing in England: Adult Psychiatric Morbidity Survey 2014. Leeds: NHS Digital, pp 37–68.
28.
SteelZMarnaneCIranpourC, et al.(2014) The global prevalence of common mental disorders: A systematic review and meta-analysis 1980-2013. International Journal of Epidemiology43(2): 476–493. DOI: 10.1093/ije/dyu038.
29.
Stone M, Laughren T, Jones ML, et al. (2009) Risk of suicidality in clinical trials of antidepressants in adults: Analysis of proprietary data submitted to US Food and Drug Administration. BMJ 339:. DOI: 10.1136/bmj.b2880.
Tseng W-S (2001) Section D: Culture and psychopathology. In: Handbook of Cultural Psychiatry, first edition. San Diego, CA: Academic Press, pp. 513–610.
33.
World Health Organisation (1993) The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research, Geneva, Switzerland: World Health Organisation.
